> These powerful middlemen may be profiting by inflating drug costs and squeezing Main Street pharmacies,” the FTC said in its findings, two years into an inves

> These powerful middlemen may be profiting by inflating drug costs and squeezing Main Street pharmacies,” the FTC said in its findings, two years into an investigation of top PBMs and their impact on prescription drug prices in the United States. Considering they are publicly listed businesses, their profit margins are available for all to see: https://www.macrotrends.net/stocks/charts/UNH/unitedhealth-group/profit-margins https://www.macrotrends.net/stocks/charts/UNH/unitedhealth-g... https://www.macrotrends.net/stocks/charts/CI/cigna-group/profit-margins https://www.macrotrends.net/stocks/charts/CI/cigna-group/pro... https://www.macrotrends.net/stocks/charts/CVS/cvs-health/profit-margins https://www.macrotrends.net/stocks/charts/CVS/cvs-health/pro... Low single digit profit margins don’t seem problematic to me. What seems to be happening is managed care organizations (aka health insurance companies) are able to squeeze dispensing pharmacies due to more negotiating power. The alternative would be raising insurance premiums.